Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnetically enhanced radionuclide therapy

R R Raylman1, R L Wahl

  • 1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109-0552.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and evaluation of a large radiation detector for Positron Emission Tomography applications.

Journal of instrumentation : an IOP and SISSA journal·2025
Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022
Same author

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022
Same author

Evaluation of Hamamatsu PET imaging modules for dedicated TOF-capable scanners.

IEEE transactions on radiation and plasma medical sciences·2021
Same author

Factors affecting the repeatability of gamma camera calibration for quantitative imaging applications using a sealed source.

Physics in medicine and biology·2015
Same author

Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer.

Practical radiation oncology·2014
Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles

Magnetically enhanced radionuclide therapy (MERiT) uses magnetic fields to confine radiopharmaceutical particles within tumors. This approach significantly increases radiation dose to cancer cells while reducing damage to healthy tissues.

Area of Science:

  • Oncology
  • Medical Physics

Background:

  • Radiopharmaceutical therapy is a common cancer treatment using radiolabeled agents that accumulate in tumors.
  • The efficacy of current radiopharmaceutical therapy is limited by tumor size, as emitted particles can escape small tumors before delivering a therapeutic dose.

Purpose of the Study:

  • To investigate the potential of using static magnetic fields to enhance the efficacy of radiopharmaceutical therapy.
  • To determine if magnetic fields can confine emitted radiation particles within tumor boundaries.

Main Methods:

  • Computer simulations were performed to model radionuclide treatments using isotopes like 131I, 186Re, and 90Y.
  • A static magnetic field was applied post-radiopharmaceutical localization to constrain emitted particles to helical paths within tumors.

Related Experiment Videos

Main Results:

  • Simulations demonstrated that a 10 Tesla magnetic field can increase the radiation dose to tumors by up to 71%.
  • The application of magnetic fields significantly reduced the radiation dose delivered to surrounding healthy tissues.

Conclusions:

  • Magnetically enhanced radionuclide therapy (MERiT) shows significant promise for improving cancer treatment outcomes.
  • MERiT warrants further investigation as an effective therapeutic strategy for various cancers.